- Home
- PMT vs RCUS Comparison
PMT vs RCUS Comparison
Compare PMT & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- RCUS
- Stock Information
- Founded
- PMT 2009
- RCUS 2015
- Country
- PMT United States
- RCUS United States
- Employees
- PMT N/A
- RCUS N/A
- Industry
- PMT Real Estate Investment Trusts
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- RCUS Health Care
- Exchange
- PMT Nasdaq
- RCUS Nasdaq
- Market Cap
- PMT 1.1B
- RCUS 906.4M
- IPO Year
- PMT 2009
- RCUS 2018
- Fundamental
- Price
- PMT $12.69
- RCUS $9.23
- Analyst Decision
- PMT Buy
- RCUS Buy
- Analyst Count
- PMT 8
- RCUS 8
- Target Price
- PMT $14.64
- RCUS $20.86
- AVG Volume (30 Days)
- PMT 871.9K
- RCUS 891.1K
- Earning Date
- PMT 07-22-2025
- RCUS 08-07-2025
- Dividend Yield
- PMT 12.61%
- RCUS N/A
- EPS Growth
- PMT N/A
- RCUS N/A
- EPS
- PMT 0.86
- RCUS N/A
- Revenue
- PMT $591,251,000.00
- RCUS $141,000,000.00
- Revenue This Year
- PMT N/A
- RCUS N/A
- Revenue Next Year
- PMT $15.69
- RCUS $28.73
- P/E Ratio
- PMT $14.76
- RCUS N/A
- Revenue Growth
- PMT N/A
- RCUS N/A
- 52 Week Low
- PMT $11.77
- RCUS $6.50
- 52 Week High
- PMT $14.93
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- PMT 48.82
- RCUS 54.47
- Support Level
- PMT $12.45
- RCUS $9.13
- Resistance Level
- PMT $12.89
- RCUS $9.62
- Average True Range (ATR)
- PMT 0.23
- RCUS 0.46
- MACD
- PMT -0.05
- RCUS 0.06
- Stochastic Oscillator
- PMT 25.54
- RCUS 66.45
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.